Frontiers in Pharmacology (Mar 2023)
Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
Abstract
No abstracts available.Keywords
Frontiers in Pharmacology (Mar 2023)